Mexico · Delayed Price · Currency is MXN Vitro Statistics
Total Valuation
Vitro has a market cap or net worth of MXN 2.28 billion. The enterprise value is 3.20 billion.
| Market Cap | 2.28B |
| Enterprise Value | 3.20B |
Important Dates
The next estimated earnings date is Thursday, February 25, 2027.
| Earnings Date | Feb 25, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
Vitro has 470.03 million shares outstanding. The number of shares has decreased by -0.83% in one year.
| Current Share Class | 470.03M |
| Shares Outstanding | 470.03M |
| Shares Change (YoY) | -0.83% |
| Shares Change (QoQ) | +5.09% |
| Owned by Insiders (%) | 72.59% |
| Owned by Institutions (%) | 0.36% |
| Float | 41.39M |
Valuation Ratios
The trailing PE ratio is 1.30.
| PE Ratio | 1.30 |
| Forward PE | n/a |
| PS Ratio | 0.44 |
| PB Ratio | 3.10 |
| P/TBV Ratio | 3.29 |
| P/FCF Ratio | 0.88 |
| P/OCF Ratio | 0.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.75, with an EV/FCF ratio of 1.23.
| EV / Earnings | 1.55 |
| EV / Sales | 0.62 |
| EV / EBITDA | 30.75 |
| EV / EBIT | n/a |
| EV / FCF | 1.23 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 1.52.
| Current Ratio | 0.91 |
| Quick Ratio | 0.91 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | 8.02 |
| Debt / FCF | 0.43 |
| Interest Coverage | -0.88 |
Financial Efficiency
Return on equity (ROE) is 23.97% and return on invested capital (ROIC) is -1.78%.
| Return on Equity (ROE) | 23.97% |
| Return on Assets (ROA) | -0.81% |
| Return on Invested Capital (ROIC) | -1.78% |
| Return on Capital Employed (ROCE) | -2.78% |
| Weighted Average Cost of Capital (WACC) | 10.56% |
| Revenue Per Employee | 11.82M |
| Profits Per Employee | 4.69M |
| Employee Count | 468 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 21.82 |
Taxes
| Income Tax | -31.34M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.80% in the last 52 weeks. The beta is 0.26, so Vitro's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -15.80% |
| 50-Day Moving Average | 4.41 |
| 200-Day Moving Average | 5.35 |
| Relative Strength Index (RSI) | 68.18 |
| Average Volume (20 Days) | 2,146 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitro had revenue of MXN 5.20 billion and earned 2.06 billion in profits. Earnings per share was 3.73.
| Revenue | 5.20B |
| Gross Profit | 1.99B |
| Operating Income | -255.75M |
| Pretax Income | 1.63B |
| Net Income | 2.06B |
| EBITDA | 114.96M |
| EBIT | -255.75M |
| Earnings Per Share (EPS) | 3.73 |
Balance Sheet
The company has 197.14 million in cash and 1.12 billion in debt, with a net cash position of -918.50 million or -1.95 per share.
| Cash & Cash Equivalents | 197.14M |
| Total Debt | 1.12B |
| Net Cash | -918.50M |
| Net Cash Per Share | -1.95 |
| Equity (Book Value) | 736.30M |
| Book Value Per Share | 1.57 |
| Working Capital | -424.68M |
Cash Flow
In the last 12 months, operating cash flow was 2.99 billion and capital expenditures -395.12 million, giving a free cash flow of 2.59 billion.
| Operating Cash Flow | 2.99B |
| Capital Expenditures | -395.12M |
| Depreciation & Amortization | 387.72M |
| Net Borrowing | -3.05B |
| Free Cash Flow | 2.59B |
| FCF Per Share | 5.51 |
Margins
Gross margin is 38.27%, with operating and profit margins of -4.92% and 39.71%.
| Gross Margin | 38.27% |
| Operating Margin | -4.92% |
| Pretax Margin | 31.44% |
| Profit Margin | 39.71% |
| EBITDA Margin | 2.21% |
| EBIT Margin | -4.92% |
| FCF Margin | 48.45% |
Dividends & Yields
Vitro does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.83% |
| Shareholder Yield | 0.83% |
| Earnings Yield | 76.85% |
| FCF Yield | 113.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on May 8, 1995. It was a forward split with a ratio of 1.2.
| Last Split Date | May 8, 1995 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Vitro has an Altman Z-Score of 0.45 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.45 |
| Piotroski F-Score | 5 |